{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:54:55Z","timestamp":1792731295852,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.pharep.2014.03.013","type":"journal-article","created":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T04:30:10Z","timestamp":1397622610000},"page":"722-725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Partial effects of the protein kinase C inhibitor chelerythrine in a battery of tests for manic-like behavior in black Swiss mice"],"prefix":"10.1007","volume":"66","author":[{"given":"Haim","family":"Einat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"7","key":"10.1016\/j.pharep.2014.03.013_bib0005","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2165\/00023210-200923070-00003","article-title":"Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder","volume":"23","author":"Zarate","year":"2009","journal-title":"CNS Drugs"},{"issue":"3\u20134","key":"10.1016\/j.pharep.2014.03.013_bib0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000106054","article-title":"Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder","volume":"55","author":"Einat","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pharep.2014.03.013_bib0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pnpbp.2012.11.015","article-title":"Protein kinase C regulates mood-related behaviors and adult hippocampal cell proliferation in rats","author":"Abrial","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.pharep.2014.03.013_bib0020","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.pnpbp.2008.09.023","article-title":"The antimanic-like effect of tamoxifen: behavioural comparison with other PKC-inhibiting and antiestrogenic drugs","volume":"32","author":"Sabioni","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.pharep.2014.03.013_bib0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archgenpsychiatry.2007.43","article-title":"Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen","volume":"65","author":"Yildiz","year":"2008","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.pharep.2014.03.013_bib0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archpsyc.57.1.95","article-title":"A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania","volume":"57","author":"Bebchuk","year":"2000","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"10.1016\/j.pharep.2014.03.013_bib0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1399-5618.2007.00530.x","article-title":"Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study","volume":"9","author":"Zarate","year":"2007","journal-title":"Bipolar Disord"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2014.03.013_bib0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0006-8993(97)00866-4","article-title":"Protein kinases A and C are involved in the mechanisms underlying consolidation of cocaine place conditioning","volume":"775","author":"Cervo","year":"1997","journal-title":"Brain Res"},{"issue":"6","key":"10.1016\/j.pharep.2014.03.013_bib0045","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.neuropharm.2011.01.037","article-title":"Antidepressant phenotype by inhibiting the phospholipase Cbeta(1) \u2013 protein kinase Cgamma pathway in the forced swim test","volume":"60","author":"Galeotti","year":"2011","journal-title":"Neuropharmacology"},{"issue":"42","key":"10.1016\/j.pharep.2014.03.013_bib0050","doi-asserted-by":"crossref","first-page":"17957","DOI":"10.1073\/pnas.0908563106","article-title":"Inhibition of protein kinase C signaling protects prefrontal cortex dendritic spines and cognition from the effects of chronic stress","volume":"106","author":"Hains","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.pharep.2014.03.013_bib0055","first-page":"1","article-title":"Strain Specific battery of tests for separate behavioral domains of mania","volume":"1","author":"Flaisher-Grinberg","year":"2010","journal-title":"Front Psychiatry"},{"issue":"1","key":"10.1016\/j.pharep.2014.03.013_bib0060","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbr.2011.04.047","article-title":"Modeling mania: further validation for black Swiss mice as model animals","volume":"223","author":"Hannah-Poquette","year":"2011","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.pharep.2014.03.013_bib0065","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/0269881108097905","article-title":"Models of mania: from facets to domains and from animal models to model animals","volume":"24","author":"Flaisher-Grinberg","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharep.2014.03.013_bib0070","series-title":"Mice models for mood and anxiety disorders","first-page":"297","article-title":"Mice models for the manic pole of bipolar disorder","author":"Flaisher-Grinberg","year":"2009"},{"key":"10.1016\/j.pharep.2014.03.013_bib0075","first-page":"1","article-title":"Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK-3) inhibitors in a strain specific model of acute mania","volume":"6","author":"Kalinichev","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"10.1016\/j.pharep.2014.03.013_bib0080","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.npp.1301254","article-title":"Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium","volume":"32","author":"Gould","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pharep.2014.03.013_bib0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0006-8993(98)01258-X","article-title":"Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests","volume":"835","author":"Crawley","year":"1999","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.pharep.2014.03.013_bib0090","first-page":"1","article-title":"Black Swiss mice as a new animal model for mania: a preliminary study","volume":"1","author":"Hiscock","year":"2007","journal-title":"J Med Biol Sci"},{"issue":"1","key":"10.1016\/j.pharep.2014.03.013_bib0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneumeth.2008.09.018","article-title":"Attenuation of high sweet solution preference by mood stabilizers: a possible mouse model for the increased reward-seeking domain of mania","volume":"177","author":"Flaisher-Grinberg","year":"2009","journal-title":"J Neurosci Methods"},{"issue":"3","key":"10.1016\/j.pharep.2014.03.013_bib0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.vascn.2009.03.003","article-title":"A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior","volume":"59","author":"Flaisher-Grinberg","year":"2009","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.pharep.2014.03.013_bib0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1876523801104010018","article-title":"Amphetamine-induced conditioned place preference test and modeling domains of bipolar disorder","volume":"4","author":"Flaisher-Grinberg","year":"2011","journal-title":"Open J Neuropsychopharmacol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S173411401400142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S173411401400142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:35:28Z","timestamp":1752611728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2014.03.013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S173411401400142X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2014.03.013","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Partial effects of the protein kinase C inhibitor chelerythrine in a battery of tests for manic-like behavior in black Swiss mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2014.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}